Clinical Trial Update: A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration [Phase 1, Phase 2]

View source ↗

Summary

A one-time intravitreal injection of SAR446597 for Geographic Atrophy due to Age-related Macular Degeneration is in a combined Phase 1/2 trial and currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• SAR446597

Snippet

Sponsor: Sanofi | Conditions: Geographic Atrophy | Phase 1, Phase 2 | Status: RECRUITING